Mereo BioPharma Group Plc (MREO)
0.3066
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.30
-0.01
(-2.15%)
After-Hours: 19:59
Mereo BioPharma Group Total Liabilities (Quarterly) : 5.872M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.872M |
| June 30, 2026 | 6.062M |
| March 31, 2026 | 6.56M |
| December 31, 2025 | 5.001M |
| September 30, 2025 | 7.004M |
| June 30, 2025 | 8.454M |
| Date | Value |
|---|---|
| March 31, 2025 | 8.241M |
| December 31, 2024 | 15.42M |
| September 30, 2024 | 16.21M |
| June 30, 2024 | 17.48M |
| March 31, 2024 | 13.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 7.330M |
| BioNTech SE | 2.797B |
| Silence Therapeutics Plc | -- |
| Autolus Therapeutics Plc | 495.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.58M |
| Shareholders Equity (Quarterly) | 23.71M |
| Debt to Equity Ratio | 0.0243 |
| Current Ratio | 5.219 |
| Net Debt Paydown Yield | 0.01% |